These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 27427769)
1. A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme. Bullard-Feibelman KM; Fuller BP; Geiss BJ PLoS One; 2016; 11(7):e0158923. PubMed ID: 27427769 [TBL] [Abstract][Full Text] [Related]
2. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme. Feibelman KM; Fuller BP; Li L; LaBarbera DV; Geiss BJ Antiviral Res; 2018 Jun; 154():124-131. PubMed ID: 29680670 [TBL] [Abstract][Full Text] [Related]
3. Development of an ELISA assay for screening inhibitors against divalent metal ion dependent alphavirus capping enzyme. Kaur R; Mudgal R; Narwal M; Tomar S Virus Res; 2018 Sep; 256():209-218. PubMed ID: 29958924 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase. Mudgal R; Mahajan S; Tomar S FEBS Lett; 2020 Feb; 594(4):678-694. PubMed ID: 31623018 [TBL] [Abstract][Full Text] [Related]
5. Guanosine nucleotide analogs as inhibitors of alphavirus mRNA capping enzyme. Lampio A; Ahola T; Darzynkiewicz E; Stepinski J; Jankowska-Anyszka M; Kääriäinen L Antiviral Res; 1999 May; 42(1):35-46. PubMed ID: 10333141 [TBL] [Abstract][Full Text] [Related]
6. Viral methyltransferase inhibitors: berbamine, venetoclax, and ponatinib as efficacious antivirals against chikungunya virus. Bhutkar M; Saha A; Tomar S Arch Biochem Biophys; 2024 Sep; 759():110111. PubMed ID: 39111614 [TBL] [Abstract][Full Text] [Related]
8. A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development. Geiss BJ; Stahla-Beek HJ; Hannah AM; Gari HH; Henderson BR; Saeedi BJ; Keenan SM J Biomol Screen; 2011 Sep; 16(8):852-61. PubMed ID: 21788392 [TBL] [Abstract][Full Text] [Related]
9. Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery. Abdelnabi R; Kovacikova K; Moesslacher J; Donckers K; Battisti V; Leyssen P; Langer T; Puerstinger G; Quérat G; Li C; Decroly E; Tas A; Marchand A; Chaltin P; Coutard B; van Hemert M; Neyts J; Delang L Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340991 [TBL] [Abstract][Full Text] [Related]
10. Structural insights into viral RNA capping and plasma membrane targeting by Chikungunya virus nonstructural protein 1. Zhang K; Law YS; Law MCY; Tan YB; Wirawan M; Luo D Cell Host Microbe; 2021 May; 29(5):757-764.e3. PubMed ID: 33730549 [TBL] [Abstract][Full Text] [Related]
11. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses. Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081 [TBL] [Abstract][Full Text] [Related]
12. Structural basis and dynamics of Chikungunya alphavirus RNA capping by nsP1 capping pores. Jones R; Hons M; Rabah N; Zamarreño N; Arranz R; Reguera J Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2213934120. PubMed ID: 36913573 [TBL] [Abstract][Full Text] [Related]
13. Critical residues for GTP methylation and formation of the covalent m7GMP-enzyme intermediate in the capping enzyme domain of bamboo mosaic virus. Huang YL; Han YT; Chang YT; Hsu YH; Meng M J Virol; 2004 Feb; 78(3):1271-80. PubMed ID: 14722282 [TBL] [Abstract][Full Text] [Related]
14. Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. Ahola T; Kääriäinen L Proc Natl Acad Sci U S A; 1995 Jan; 92(2):507-11. PubMed ID: 7831320 [TBL] [Abstract][Full Text] [Related]
15. Palmitoylated Cysteines in Chikungunya Virus nsP1 Are Critical for Targeting to Cholesterol-Rich Plasma Membrane Microdomains with Functional Consequences for Viral Genome Replication. Bakhache W; Neyret A; Bernard E; Merits A; Briant L J Virol; 2020 May; 94(10):. PubMed ID: 32132240 [TBL] [Abstract][Full Text] [Related]
16. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay. Ferreira-Ramos AS; Li C; Eydoux C; Contreras JM; Morice C; Quérat G; Gigante A; Pérez Pérez MJ; Jung ML; Canard B; Guillemot JC; Decroly E; Coutard B Antiviral Res; 2019 Mar; 163():59-69. PubMed ID: 30639438 [TBL] [Abstract][Full Text] [Related]
17. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents. Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048 [TBL] [Abstract][Full Text] [Related]
18. Critical residues of Semliki Forest virus RNA capping enzyme involved in methyltransferase and guanylyltransferase-like activities. Ahola T; Laakkonen P; Vihinen H; Kääriäinen L J Virol; 1997 Jan; 71(1):392-7. PubMed ID: 8985362 [TBL] [Abstract][Full Text] [Related]
19. 6'-β-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1. Kovacikova K; Morren BM; Tas A; Albulescu IC; van Rijswijk R; Jarhad DB; Shin YS; Jang MH; Kim G; Lee HW; Jeong LS; Snijder EJ; van Hemert MJ Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964798 [TBL] [Abstract][Full Text] [Related]
20. The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection. Delang L; Li C; Tas A; Quérat G; Albulescu IC; De Burghgraeve T; Guerrero NA; Gigante A; Piorkowski G; Decroly E; Jochmans D; Canard B; Snijder EJ; Pérez-Pérez MJ; van Hemert MJ; Coutard B; Leyssen P; Neyts J Sci Rep; 2016 Aug; 6():31819. PubMed ID: 27545976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]